hansoh glp 1 Pharma patents new GLP-1R agonists GSK taps Hansoh for another

Let's look at the research: People who took the maximum dose of tirzepatide over 72 weeks lost an average of 21 percent of their body weight, according to data from clinical trials published in The New England Journal of Medicine in 2022

10.1007/s00592-025-02468-5 26 The Diabetes Prevention Program (DPP) (2002)

Portable 7.9mL small bottles, easy to carry for on-the-go wellness support (work, travel).

Mindless eating just isnt a thing anymore

population will be taking these drugs by 2035, and the market would cross $100 billion by 2030

Social and relationship transformation Weight loss changes how people interact with the world, and how the world interacts with them